Delaware Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 3 (100% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 756
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 83.86%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 63
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 81.36%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 10.05% 17.46%
White, Hispanic/Latino Patients 18.12% 20.63%
Black/African American, Non-Hispanic/Latino Patients 25.93% 50.79%
Black/African American, Hispanic/Latino Patients 0.93% 3.17%
Asian Patients3 0.79% 0.00%
American Indian/Alaska Native Patients3 0.40% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.53% 0.00%
Patients with More than one race3 2.25% 1.59%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.31% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.59% 1.59%
Unreported/Refused to Report Race and Ethnicity 36.11% 4.76%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 330
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 91.91%
COVID-19 Immunization Series Completed 559
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 90.39%
COVID-19 Immunization Series Additional 1
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 0.00%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 7.58% 8.77% 100.00%
White, Hispanic/Latino Patients 36.06% 43.83% 0.00%
Black/African American, Non-Hispanic/Latino Patients 20.30% 17.17% 0.00%
Black/African American, Hispanic/Latino Patients 1.21% 0.72% 0.00%
Asian Patients3 0.61% 0.54% 0.00%
American Indian/Alaska Native Patients3 1.21% 0.72% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 1.21% 0.89% 0.00%
Patients with More than one race3 2.12% 1.97% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 23.33% 16.64% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.12% 1.97% 0.00%
Unreported/Refused to Report Race and Ethnicity 4.24% 6.80% 0.00%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 33.33%
More Than 24 Hours 66.67%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 100.00%
Vaccine confidence 66.67%
Vaccine storage capacity 33.33%
Vaccine supply 0.00%
Other 0.00%
None 0.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 81.67%
Average Percent of Health Center Visits Conducted Virtually 28.33%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 33.33%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 33.33%
None 66.67%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 33.33%
Patient awareness/education 33.33%
Staffing capacity 66.67%
Therapy administration/onsite logistics 66.67%
Other 0.00%
None 33.33%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021